Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-response of nitroglycerin to prevent pituitrin-induced hemodynamic response during laparoscopic myomectomy
ChiCTR2200062282Phase 4Not yet recruiting
- Sponsor
- Jiaxing Maternity and Child Health Care Hospital
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nitroglycerin in hypertension (HTN) (4 arms), sponsored by Jiaxing Maternity and Child Health Care Hospital. Primary endpoints: Half effective dose (ED50) and 95% effective dose (ED95) of nitroglycerin, Blood pressure and 1 more. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
nitroglycerin
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR2200062282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062282.